awmsg logo



dapoxetine (Priligy®)


Reference No. 1671

Publication date:
13/08/2012


Appraisal information

dapoxetine (Priligy®) film-coated tablet


Company: A. Menarini Farmaceutica Internazionale SRL
BNF category: Obstetrics, gynaecology, and urinary-tract disorders
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 07/08/2012

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, dapoxetine (Priligy®) cannot be endorsed for use within NHS Wales for the treatment of premature ejaculation in men aged 18 to 64 years old.
Statement of Advice (SOA)
Download